June 4, 2023
2 mins read

Shortage forces US to import Chinese cancer drug

Cisplatin, a generic drug available for decades in the US, has faced national shortage since February…reports Asian Lite News

In a bid to ease the ongoing shortage of chemotherapy in the US, the country’s Food and Drug Administration (FDA) has allowed for a temporary import of the cancer drug made in China.

Chinese drug maker Qilu Pharmaceutical has received the FDA approval for their cisplatin injections, CNBC reported.

The injectable medication will be distributed in the US in 50-milligram vials on a temporary basis by Canadian drug maker Apotex. It will be available for order by health care providers starting Tuesday.

“The FDA recognises the importance of a stable, safe supply of critical drugs used in oncology, especially those used in potentially curative or life-extending situations,” FDA Commissioner Dr Robert Califf said on Twitter.

“Today, we’ve taken steps for temporary importation of certain foreign-approved versions of cisplatin products from FDA-registered facilities and used regulatory discretion for continued supply of other cisplatin and carboplatin products to help meet patient needs.

“In these situations, we very carefully assess product quality and require companies to take certain measures to ensure the products are safe for patients. The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” he noted.

High-Fibre Diet May Lower Colon Cancer Risk

Cisplatin, a generic drug available for decades in the US, has faced national shortage since February after an Indian pharmaceutical company temporarily halted production for the US market.

According to the US National Cancer Institute, Cisplatin and other platinum-based drugs are prescribed for 10 per cent to 20 per cent of all cancer patients. Cisplatin has a cure rate of over 90 per cent when used to treat testicular cancer. It also treats bladder, cervical, ovarian, lung, gastric, breast, and head and neck cancers.

The severe shortage of cisplatin and carboplatin, “the chemotherapy backbone”, is affecting hundreds of thousands of patients across the US, Dr. Amanda Fader, a professor at the Johns Hopkins School of Medicine, was quoted as saying to CNN.

Qilu’s version of cisplatin is not approved in the US. An FDA spokesperson said the agency assesses the quality of unapproved drug imports to make sure they are safe for US patients. At least 13 other cancer drugs are in short supply across the US.

ALSO READ: China ‘weaponsing’ investment on foreign soil

Previous Story

India, Maldives ink 10 MoUs to cement ties

Next Story

Carefully crafted for sustainability and style

Latest from -Top News

Pakistan FM Due in Bangladesh

During his visit Dar will hold discussions with the Foreign Affairs Advisor Towhid Hossain and also call on Muhammad Yunus…reports Asian Lite News Pakistan’s Deputy Prime Minister and Foreign Minister Ishaq Dar

Balochistan: Where the State Makes People Disappear

The victims include students, journalists, and peaceful protesters, many of whom were abducted from cities such as Karachi and Islamabad….reports Asian Lite News A human rights organisation on Monday revealed that 785

Monsoon Havoc in Pakistan

Since June 26, torrential rains have killed at least 299 people—including 140 children—and injured 715 in Pakistan…reports Asian Lite News Since June 26, torrential monsoon rains have devastated Pakistan, killing at least

Bangladesh’s Dark Turn

With the Awami League outlawed and absent from the electoral fray, a vacuum has emerged — one that has not necessarily been filled with stability….reports Asian Lite News Bangladesh’s political landscape has
Go toTop

Don't Miss

WHO likely to restudy Wuhan lab origin theory of Covid-19

The WHO report’s annex contains multiple data points providing an

China slams US over demands to close Xinjiang Tesla showroom

The move by Tesla comes at a time when US